Mark Hiley speaks at the Value Invest Quorum by Convene event
Our founder and CEO, Mark Hiley, spoke at the Value Invest Quorum by Convene event today.
The Analyst celebrate partnership with Sarcoma UK at special event 10 Downing Street
Our Founder Mark Hiley accepted an award on behalf of The Analyst at from a national cancer charity at a ceremony in Downing Street.
It is in the UK’s interest to treat investment research as a public good
We featured in the Financial Times today talking about the challenges of independent research.
Bubbelvarnade för Embracer 2019: ”Borde ha lyssnat”
Out Stocks in the News – new article in Dagen Industri
For bear stock pickers, 2023 is full of rich pickings
The Analyst is featured Reuter article focusing on how Short researchers use forensic accounting, lessons learned and their expectations for 2023.
Sarcoma UK thanks £1 million partner with reception at the Lord Mayor’s Mansion House
We celebrated our partnership with Sarcoma UK last week at a reception and silent auction held at Mansion House.
Firman som sänkte Evolution: ”Vi gör inte köpta analyser”
Our Stocks in the News – new article in Dagen Industri
The shares that brokers are backing for 2022
Our Stocks in the News – new article in the Investors’ Chronicle
Our Fundraising Heros: Sarcoma UK celebrates ten years
Our charity partner, Sarcoma UK, are celebrating their tenth anniversary.
Deliveroo share price: Mark Hiley predicts 40% drop before bottom hits
Our Stocks in the News – new article in IG
